Core Insights - Orchestra BioMed Holdings, Inc. announced an industry-sponsored satellite symposium at the Heart Rhythm Society 2025 Annual Meeting to discuss advancements in its atrioventricular interval modulation (AVIM) therapy program [1][4] - The FDA granted Breakthrough Device Designation to AVIM therapy for treating hypertension in patients with increased cardiovascular risk, highlighting the unmet need in this patient population [2][4] - The BACKBEAT global pivotal study is currently enrolling patients to evaluate the efficacy of AVIM therapy in managing uncontrolled hypertension [2][9] Company Overview - Orchestra BioMed is a biomedical innovation company focused on accelerating high-impact technologies through partnerships with leading medical device companies [7] - The company's lead product candidate is AVIM therapy, aimed at treating hypertension, which is a leading risk factor for death globally [7] - Orchestra BioMed has strategic collaborations with Medtronic for AVIM therapy and Terumo for the Virtue Sirolimus AngioInfusion Balloon [7] Symposium Details - The symposium titled "The Future of Cardiac Pacing: Unlocking the Potential of Atrioventricular Interval Modulation (AVIM) Therapy" will take place on April 25, 2025, at the Hilton San Diego Bayfront Hotel [3] - Presentations will cover clinical results from studies demonstrating AVIM therapy's effectiveness in reducing blood pressure and improving cardiac function [4][5] - Key presentations will include topics on the unmet hypertension need, AVIM therapy's impact on hypertension, and the rationale behind the BACKBEAT study [5][6] Clinical Evidence - AVIM therapy has shown promising results in pilot studies, with reductions of 8.1 mmHg in 24-hour ambulatory systolic blood pressure and 12.3 mmHg in office systolic blood pressure at six months compared to control patients [9] - The BACKBEAT study aims to further evaluate the safety and efficacy of AVIM therapy in patients with uncontrolled hypertension despite anti-hypertensive medication [9]

Core Insights - TeleVox has launched Insights360, a cloud-based analytics solution designed to enhance patient call experiences by analyzing every aspect from dial to disconnect [1][3] - The technology records calls within the telecom network and generates patient-centered data, focusing on the customer's perspective rather than the agent's [3][4] Product Features - Insights360 provides customized analytics to identify specific challenges in healthcare organizations, enabling smarter self-service and reduced operational costs [4] - The solution offers actionable insights, such as identifying network connectivity issues, reasons for agent transfers, and analyzing repeat calls for better resolution [4] Industry Context - TeleVox serves over 7,000 healthcare organizations, integrating its patient relationship management platform with electronic health records to facilitate two-way interactions [6] - The company has been in operation for 30 years, focusing on improving healthcare communication and reducing the operational burden on staff [6][7] Upcoming Events - TeleVox will showcase Insights360 at the Becker's Healthcare Annual Meeting from April 28 to May 1 in Chicago, where attendees can participate in live demos and workshops [5]

Company Overview - Willis Lease Finance Corporation (WLFC) is a leading lessor of commercial aircraft engines and a global provider of aviation services [1][4] - The company operates through various subsidiaries, including Willis Aviation Services Limited (WASL), which specializes in aircraft maintenance, repair, and overhaul (MRO) services [1][4] Expansion Plans - WASL has commenced construction of a new two-bay narrowbody hangar at Teesside International Airport, aimed at accommodating 737 and A320 family aircraft, including new-generation models [1][2] - This expansion is a response to the exceptionally high demand for aircraft heavy maintenance, with global and European MRO capacity currently falling short [2] Job Creation and Training Initiatives - The new facility is expected to create a significant number of highly-skilled jobs in the Teesside region [2] - WASL is partnering with local universities and colleges to launch training programs for new mechanics and apprentices, ensuring a sustainable talent pipeline for the aviation industry [2][3] Commitment to Community - The company has made a commitment to create several hundred jobs in Northeast England and is actively following through on this pledge [3] - WLFC's integrated services support both third-party customers and the company's owned and managed assets, contributing to growth and opportunities in local communities [3]

Core Viewpoint - Research Frontiers Inc. announced the integration of its SPD-SmartGlass technology in the new Mercedes-Benz Vision V show car, showcasing the growing adoption of this technology in the automotive industry to enhance comfort, energy efficiency, and personalization [1][2][6]. Group 1: Technology and Innovation - Approximately 75% of the Vision V's glazing area features SPD-SmartGlass technology, highlighting its significant role in modern automotive design [2]. - The Vision V marks the first use of Gauzy's dual smart glass stack, combining SPD and PDLC technologies, allowing for seamless transitions between different glass states [5]. - SPD-SmartGlass technology has been adopted by other luxury automotive brands, including Cadillac, Ferrari, and McLaren, as well as in various aircraft and architectural projects, demonstrating its versatility [4]. Group 2: Benefits of SPD-SmartGlass - SPD-SmartGlass can reduce cabin temperatures by up to 18 degrees Fahrenheit (10 degrees Celsius), leading to smaller air conditioning systems and improved energy efficiency [7]. - The technology allows for instantaneous adjustment to light and heat conditions, providing a more comfortable passenger experience [7]. - By reducing air conditioning loads, SPD-SmartGlass can extend the driving range of vehicles by up to 5.5% and decrease CO2 emissions by up to 4 grams per kilometer [7]. Group 3: Industry Impact - The continued reliance on SPD-SmartGlass by Mercedes-Benz signifies its importance in the future of luxury mobility, especially as the industry shifts towards electric and autonomous vehicles [6]. - Research Frontiers emphasizes its commitment to supporting the growing adoption of SPD-SmartGlass technology worldwide, indicating a strong market presence and potential for future growth [6].

Core Insights - Bobbie, a new influencer and creator marketing solution, has been launched by HUNTER, a Stagwell agency, focusing on technology-powered and human-centered approaches to influencer marketing [1][12] - The agency aims to bridge the gap between the increasing demand for influencer marketing and the current lack of dedicated teams managing these programs [5][11] Company Overview - Bobbie is designed to provide end-to-end influencer marketing services, leveraging data, consumer insights, and AI to enhance brand relationships with consumers [4][12] - The leadership team at Bobbie includes experienced professionals from the influencer marketing and digital media sectors, ensuring a robust network for cultivating creator relationships [7][8] Market Trends - A significant increase in marketers planning to allocate dedicated budgets for influencer marketing is noted, with 75% expected to do so in 2025, up from 37% in 2017 [5][10] - Over 80% of marketers consider influencer marketing essential, yet only 24% have dedicated teams for these initiatives, indicating a substantial opportunity for agencies like Bobbie [5][11] Strategic Focus - Bobbie emphasizes the importance of authentic creator relationships, as nearly half of Gen Z consumers and one in four Millennials view influencers as friends, which can drive consumer action [3][12] - The agency's approach combines seasoned human instincts with advanced technology to effectively identify and engage creators, aiming to create meaningful brand experiences [4][8]

Core Viewpoint - Shineco, Inc. has announced the acquisition of a 51% equity interest in InfiniClone Limited, a biotechnology company specializing in regenerative medicine, marking a significant step into the stem cell technology sector [2][3][6]. Company Overview - Shineco, Inc. focuses on providing innovative diagnostic medical products and related medical devices, aiming to improve quality of life through safe and efficient health solutions [7]. - The company has developed 33 types of in vitro diagnostic reagents and related medical devices, alongside producing and selling healthy foods [7]. Acquisition Details - The acquisition involves a payment of $19,895,600 in cash and the issuance of 3,450,000 shares of common stock to the seller, Dr. Lim Kah Meng [3]. - InfiniClone holds 29 global patents, including five invention patents, which cover major markets such as the US, Europe, and Asia, providing a competitive edge in stem cell technology [4]. InfiniClone's Technology - InfiniClone's core technologies include cell reprogramming, stem cell culture using microcarrier technology, and the management of induced pluripotent stem cell (iPSC) libraries, which can enhance cell expansion throughput by three to ten times compared to existing methods [4]. - The technology is expected to reduce production costs per cell by over 60% and significantly shorten the time required for clinical applications, such as treating Parkinson's and Alzheimer's diseases [4]. Leadership and Expertise - Dr. Lim Kah Meng, the founder of InfiniClone, has over 20 years of experience in molecular research related to stem cell and regenerative medicine, and has founded several biotechnology companies [5]. - Shineco's CEO, Jennifer Zhan, emphasized the acquisition as a key milestone for entering the regenerative medicine field and highlighted the potential for transforming InfiniClone's technology from laboratory to clinical applications [6].

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 23, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to announce that it has closed its previously announced, upsized equity offering for aggregate gross proceeds of $20 ...

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that financial advisor James “Jim” Verdi, CFP®, has joined LPL Financial’s broker-dealer, Registered Investment Advisor (RIA) and custodial platforms. He reported serving approximately $350 million in advisory, brokerage and retirement plan assets* and joins LPL from Osaic. Based in Smithtown, N.Y., Verdi founded Synergy Wealth Strategies in 2008, driven by the mission that investors deserve a reputable, stable and safe place to ...

Meeting further adjourned to May 1, 2025 at 8:00 a.m. Central TimeHOUSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (NYSE: AMPY) (“Amplify” or the “Company”) today announced that it intends to open and immediately adjourn its reconvened Special Meeting of Stockholders (the “Special Meeting”) relating to the Company’s proposed merger with Juniper Capital’s upstream Rocky Mountain portfolio companies. There will be no voting or other matters conducted at the meeting on April 23, 2025, and the C ...

Signs Over 10% of Statewide Installers in One Quarter; Solartek Deal Expands Distribution FootprintSAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- NeoVolta Inc. (NASDAQ: NEOV), U.S.-based energy technology company delivering scalable storage for resilient residential and commercial power infrastructure, today announced unprecedented growth in Texas. “Texas is a key market for us, and with new product introduction in the last quarter, we’ve onboarded over 10% of Texas’s solar installers as NeoVolta Certified D ...